CD274 and small cell lung carcinoma: In a retrospective study (Liu et al. 2023a) involving 612 SCLC patients receiving initial chemotherapy (with 22 also receiving PD-L1 inhibitors), NLR emerged as an independent predictive factor for SCLC cases (P = 0.004).